000			01914 a2200529 4500
005			20250511200604.0
264		0	_c19911030
008			199110s 0 0 eng d
022			_a0140-6736
024	7		_a10.1016/0140-6736(91)91511-r _2doi
040			_aNLM _beng _cNLM
100	1		_aPécoul, B
245	0	0	_aLong-acting chloramphenicol versus intravenous ampicillin for treatment of bacterial meningitis. _h[electronic resource]
260			_bLancet (London, England) _cOct 1991
300			_a862-6 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAmpicillin _xtherapeutic use
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aChloramphenicol _xtherapeutic use
650	0	4	_aDrug Resistance, Microbial
650	0	4	_aHaemophilus Infections _xdrug therapy
650	0	4	_aHaemophilus influenzae _xdrug effects
650	0	4	_aHumans
650	0	4	_aInfant
650	0	4	_aInjections, Intramuscular
650	0	4	_aInjections, Intravenous
650	0	4	_aKlebsiella pneumoniae _xdrug effects
650	0	4	_aMeningitis, Bacterial _xcomplications
650	0	4	_aMeningitis, Meningococcal _xdrug therapy
650	0	4	_aMeningitis, Pneumococcal _xdrug therapy
650	0	4	_aNeisseria meningitidis _xdrug effects
650	0	4	_aNervous System Diseases _xetiology
650	0	4	_aProteus mirabilis _xdrug effects
650	0	4	_aStreptococcus pneumoniae _xdrug effects
650	0	4	_aSurvival Rate
700	1		_aVaraine, F
700	1		_aKeita, M
700	1		_aSoga, G
700	1		_aDjibo, A
700	1		_aSoula, G
700	1		_aAbdou, A
700	1		_aEtienne, J
700	1		_aRey, M
773	0		_tLancet (London, England) _gvol. 338 _gno. 8771 _gp. 862-6
856	4	0	_uhttps://doi.org/10.1016/0140-6736(91)91511-r _zAvailable from publisher's website
999			_c1687638 _d1687638